Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option (vol 134, pg 511, 2012)

被引：0

|

作者：

Pessetto, Ziyan Yuan ^{[1
]}

Yan, Ying ^{[1
]}

Bessho, Tadayoshi ^{[1
]}

Natarajan, Amarnath ^{[1
,2
,3
]}

机构：

[1] Univ Nebraska Med Ctr, Eppley Inst Res Canc, Omaha, NE 68198 USA

[2] Univ Nebraska Med Ctr, Dept Pharmaceut Sci, Omaha, NE 68198 USA

[3] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA

来源：

BREAST CANCER RESEARCH AND TREATMENT | 2016年 / 155卷 / 03期

关键词：

D O I：

10.1007/s10549-016-3702-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：613 / 613

页数：1

相关论文

共 3 条

[1] Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option
Ziyan Yuan Pessetto
Ying Yan
Tadayoshi Bessho
Amarnath Natarajan
Breast Cancer Research and Treatment, 2012, 134 : 511 - 517
[2] Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option
Pessetto, Ziyan Yuan
Yan, Ying
Bessho, Tadayoshi
Natarajan, Amarnath
BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (02) : 511 - 517
[3] Erratum to: Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option
Ziyan Yuan Pessetto
Ying Yan
Tadayoshi Bessho
Amarnath Natarajan
Breast Cancer Research and Treatment, 2016, 155 : 613 - 613